Adicet Bio, Inc. (ACET) — Stock Score Summary

Adicet Bio, Inc. (ACET) has a MoatMap StockRank of 19/100 based on Quality (33/100), Value (42/100), and Momentum (29/100) factor scores. The current signal is STRONG SELL. Adicet Bio is a clinical-stage biotech developing cell therapies. It is pre-revenue, highly speculative, and lacks any manufacturing scale or CDMO characteristics, failing all of our quality and value screens.

Adicet Bio, Inc. is a clinical-stage biotechnology company pioneering the development of allogeneic gamma delta T-cell therapies for cancer and autoimmune diseases. The company's proprietary platform engineers off-the-shelf gamma delta T-cells with chimeric antigen receptors (CARs) to enhance tumor targeting and durability. Adicet occupies a highly specialized niche in the cellular immunotherapy landscape, leveraging the innate and adaptive immune properties of gamma delta T-cells.

Key Financial Metrics

Price$7.31
Market Cap$81M
P/E (Forward)-1.94
Price/Book0.56
Return on Equity-72.2%
Return on Invested Capital-68.4%
Debt/Equity9.92
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-49M

Adicet Bio, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Adicet Bio, Inc.’s (ACET) StockRank?
MoatMap’s StockRank for Adicet Bio, Inc. (ACET) is 19/100, with a Strong Sell signal. It is a composite of Quality (33), Value (42), and Momentum (29) factor ranks across MoatMap’s 19,000+ stock universe.
Does Adicet Bio, Inc. have an economic moat?
Adicet Bio, Inc. (ACET) has a Quality factor score of 33/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Adicet Bio, Inc. a buy, hold, or sell?
MoatMap’s current signal for Adicet Bio, Inc. (ACET) is Strong Sell, based on a StockRank of 19/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Adicet Bio, Inc. in?
Adicet Bio, Inc. (ACET) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksACET deep dive reportAI ChampionsHow we score stocksSense-check another stock